En esta página
01CGEM precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
CGEM Cullinan Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$15,51
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$5,68mínimo 52 semanas
$23,19máximo 52 semanas
Capitalización Bursátil (MRQ)
$998M
P/E
-4.8
BPA
$-3.69
tus insignias
Rango 52S
$6–$23
Calificación del Analista
STRONG BUY
Precio Objetivo
$33
P/E
-4.8
ROE
-44.0%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CGEM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$15.51
Capitalización Bursátil (MRQ)
$998M
P/E
-4.8
BPA
$-3.69
ROE
-44.0%
Rango 52S
$6–$23
CGEM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos·2020-12-31 → 2022-12-31
BPA$-3.692021-12-31 → 2023-12-31
Flujo de caja libre$-176M2022-12-31 → 2025-12-31
Margen neto·2021-12-31 → 2021-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CGEM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.8promedio 5A ≈-3.1 | ≈-3.1 | · | · | |
| P/C (MRQ) | 3.1promedio 5A ≈1.2 | ≈1.2 | 4.2 | Valor razonable | |
| Price / FCF (Precio / FCF) | -5.3promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -5.3promedio 5A ≈-6.3 | ≈-6.3 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 2.3promedio 5A ≈1.2 | ≈1.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CGEM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -41.1%promedio 5A ≈-19.7% | ≈-19.7% | -21.8% | Débil | |
| ROE | -44.0%promedio 5A ≈-21.0% | ≈-21.0% | -40.2% | Débil | |
| ROIC | -59.1%promedio 5A ≈-27.9% | ≈-27.9% | -34.2% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CGEM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 8.4promedio 5A ≈17.4 | ≈17.4 | 8.4 | En línea | |
| Quick Ratio (Ratio Rápido) | 10.0promedio 5A ≈17.0 | ≈17.0 | 1.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
4.3%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.81 | $-0.83 | 1.9% |
| 31 de marzo de 2026 | May 7, 2026 | $-0.75 | $-0.85 | 11.3% |
| 31 de diciembre de 2025 | $-0.77 | $-0.83 | 6.7% | |
| 30 de septiembre de 2025 | $-0.77 | $-0.98 | 21.1% | |
| 30 de junio de 2025 | $-1.07 | $-0.85 | -25.9% | |
| 31 de marzo de 2025 | $-0.74 | $-0.82 | 9.5% | |
| 31 de diciembre de 2024 | $-0.73 | $-0.77 | 5.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $19M | $0 | |
| R&D Expense | $187M | $143M | $148M | $92M | $58M | $43M | |
| SG&A Expense | $54M | $54M | $42M | $40M | $29M | $17M | |
| Operating Expenses | $242M | $197M | $191M | $132M | $87M | $60M | |
| Operating Income | $-242M | $-197M | $-191M | $145M | $-68M | $-60M | |
| Interest Income | $22M | $30M | $22M | $7M | $477.0K | $888.0K | |
| Other Non-op | $-443.0K | $-199.0K | $239.0K | $57.0K | $-8.0K | $-11.0K | |
| Pretax Income | $-220M | $-167M | $-169M | $151M | $-67M | · | |
| Income Tax | $0 | $117.0K | $-14M | $42M | $0 | · | |
| Net Income | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| EPS (Basic) | · | · | $-3.69 | $2.46 | $-1.52 | · | |
| EPS (Diluted) | · | · | $-3.69 | $2.38 | $-1.52 | · | |
| Shares (Basic) | · | · | 41,550,000 | 45,164,000 | 43,077,000 | · | |
| Shares (Diluted) | · | · | 41,550,000 | 46,640,000 | 43,077,000 | · | |
| EBITDA | $-241M | $-197M | $-191M | $145M | $-68M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $83M | $98M | $156M | $60M | $168M | |
| Short-term Investments | $290M | $316M | $369M | $311M | $231M | $42M | |
| Prepaid Expense | $9M | $16M | $13M | $7M | $6M | $2M | |
| Other Current Assets | · | · | $4M | · | · | · | |
| Current Assets | $387M | $415M | $480M | $474M | $297M | $212M | |
| PP&E (Net) | $421.0K | $683.0K | $989.0K | $1M | $77.0K | $130.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $309.0K | $309.0K | |
| Accum. Depreciation | $969.0K | $658.0K | $352.0K | $135.0K | $232.0K | $179.0K | |
| Other Non-current Assets | $297.0K | $366.0K | $459.0K | $459.0K | $147.0K | $2M | |
| Total Assets | $448M | $622M | $484M | $561M | $437M | $215M | |
| Accounts Payable | $841.0K | $2M | $2M | $3M | $3M | $10M | |
| Accrued Liabilities | $36M | $28M | $24M | $14M | $9M | $5M | |
| Current Liabilities | $38M | $31M | $28M | $22M | $12M | $14M | |
| Capital Leases | $2M | $849.0K | $2M | $4M | · | · | |
| Total Liabilities | $40M | $31M | $30M | $26M | $12M | $14M | |
| Common Stock | $6.0K | $6.0K | $4.0K | $5.0K | $4.0K | $3.0K | |
| Retained Earnings | $-588M | $-368M | $-201M | $-48M | $-159M | $-93M | |
| AOCI | $1M | $-133.0K | $-129.0K | $-3M | $-838.0K | $-2.0K | |
| Stockholders' Equity | $409M | $590M | $454M | $535M | $425M | $199M | |
| Liabilities + Equity | $448M | $622M | $484M | $561M | $437M | $215M | |
| Shares Outstanding | 60,244,136 | 58,510,610 | 42,900,083 | 45,796,449 | 44,292,102 | 29,831,125 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $311.0K | $306.0K | $310.0K | $93.0K | $53.0K | $62.0K | |
| Stock-based Comp | $36M | $38M | $30M | $28M | $24M | $15M | |
| Deferred Tax | · | $3M | $5M | · | $0 | $0 | |
| Other Non-cash | $8M | $-19M | $-17M | $-266M | $-2M | · | |
| Operating Cash Flow | $-176M | $-145M | $-134M | $-127M | $-43M | $-30M | |
| CapEx | $49.0K | $0 | $208.0K | $1M | $0 | $10.0K | |
| Investing Cash Flow | $180M | $-136M | $36M | $249M | $-334M | $-5M | |
| Stock Issued | $0 | $263M | $38M | $0 | $3M | $145M | |
| Stock Repurchased | · | · | · | · | · | $7M | |
| Net Stock Activity | $0 | $263M | $38M | $6M | · | · | |
| Financing Cash Flow | $1M | $266M | $41M | $-26M | $269M | $140M | |
| Taxes Paid | $-3M | $-2M | $-4M | $38M | $0 | · | |
| Free Cash Flow | $-176M | $-145M | $-134M | $-128M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -358.7% | · | |
| Net Margin | · | · | · | · | -346.1% | · | |
| EBITDA Margin | · | · | · | · | -358.4% | · | |
| ROA | -41.1% | -30.3% | -29.3% | 22.3% | -20.1% | · | |
| ROE | -44.0% | -32.1% | -31.0% | 23.2% | -21.0% | · | |
| ROIC | -59.1% | -33.4% | -38.6% | 19.5% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 | · | |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.78 | $10.09 | $10.58 | $11.68 | $9.59 | · | |
| Revenue / Share | · | · | · | $0.00 | · | · | |
| Cash Flow / Share | · | · | $-3.23 | $-2.72 | · | · | |
| Cash / Share | $1.47 | $1.42 | $2.29 | $3.41 | $1.35 | · | |
| EPS (TTM) | $-3.21 | $-3.21 | $-3.69 | $2.38 | $-1.52 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $19M | $0 | |
| Net Income TTM | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| Market Cap | $624M | $713M | $437M | $483M | $683M | · | |
| P/E | -3.2 | -3.8 | -2.8 | 4.4 | -10.2 | · | |
| P/S | · | · | · | · | 36.1 | · | |
| P/B | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Tangible Book | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Cash Flow | -3.5 | -4.9 | -3.3 | -3.8 | -15.7 | · | |
| P / FCF | -3.5 | -4.9 | -3.3 | -3.8 | · | · | |
| Earnings Yield | -31.0% | -26.4% | -36.2% | 22.6% | -9.8% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $44M | $42M | $43M | $42M | $61M | $41M | $40M | $36M | $36M | $31M | $35M | $34M | $27M | $52M | $21M | $20M | |
| SG&A Expense | $13M | $12M | $12M | $14M | $15M | $14M | $15M | $13M | $14M | $12M | $11M | $11M | $10M | $11M | $11M | $10M | |
| Operating Expenses | $57M | $54M | $55M | $56M | $76M | $55M | $55M | $49M | $50M | $43M | $45M | $45M | $38M | $63M | $33M | $30M | |
| Operating Income | $-57M | $-54M | $-55M | $-56M | $-76M | $-55M | $-55M | $-49M | $-50M | $-43M | $-45M | $-45M | $-38M | $-63M | $-33M | $-30M | |
| Interest Income | $4M | $4M | $5M | $5M | $6M | $7M | $8M | $8M | $8M | $6M | $6M | $6M | $5M | $5M | $3M | $2M | |
| Other Non-op | $-98.0K | $-62.0K | $-69.0K | $-108.0K | $-181.0K | $-85.0K | $6.0K | $-89.0K | $-72.0K | $-44.0K | $-117.0K | $180.0K | $69.0K | $107.0K | $298.0K | $0 | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-40M | $-39M | $-32M | $-58M | $-29M | $-27M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $-14M | $0 | $0 | $0 | $-2M | $-3M | |
| Net Income | $-54M | $-50M | $-51M | $-51M | $-70M | $-49M | $-48M | $-41M | $-42M | $-37M | $-24M | $-39M | $-32M | $-58M | $-27M | $-25M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.63 | $-0.54 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.58 | $-0.54 | |
| Shares (Basic) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | · | 45,611,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | · | 45,611,000 | |
| EBITDA | $-57M | $-54M | · | $-56M | $-76M | $-55M | · | $-49M | $-50M | $-43M | · | $-45M | $-38M | $-63M | · | $-30M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $75M | $88M | $103M | $73M | $77M | $83M | $102M | $115M | $74M | $98M | $65M | $142M | $122M | $156M | $243M | |
| Short-term Investments | $256M | $277M | $290M | $229M | $193M | $227M | $316M | $476M | $547M | $359M | $369M | $402M | $350M | $269M | $311M | $333M | |
| Prepaid Expense | $7M | $10M | $9M | $10M | $10M | $14M | $16M | $14M | $15M | $13M | $13M | $619.0K | $619.0K | $8M | · | $619.0K | |
| Current Assets | $342M | $361M | $387M | $342M | $276M | $318M | $415M | $592M | $678M | $446M | $480M | $477M | $498M | $399M | $474M | $582M | |
| PP&E (Net) | $263.0K | $342.0K | $421.0K | $489.0K | $569.0K | $607.0K | $683.0K | $760.0K | $836.0K | $913.0K | $989.0K | $1M | $1M | $1M | $1M | $792.0K | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $969.0K | · | · | · | $658.0K | · | · | · | $352.0K | · | · | · | $135.0K | · | |
| Other Non-current Assets | $297.0K | $297.0K | $297.0K | $361.0K | $367.0K | $366.0K | $366.0K | $460.0K | $460.0K | $460.0K | $459.0K | $459.0K | $459.0K | $459.0K | $459.0K | $460.0K | |
| Total Assets | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Accounts Payable | $4M | $3M | $841.0K | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $2M | $951.0K | $2M | $2M | $3M | $2M | |
| Accrued Liabilities | $36M | $32M | $36M | $30M | $24M | $23M | $28M | $21M | $21M | $17M | $24M | $21M | $16M | $18M | $14M | $14M | |
| Current Liabilities | $41M | $35M | $38M | $33M | $28M | $27M | $31M | $24M | $23M | $22M | $28M | $23M | $20M | $26M | $22M | $27M | |
| Capital Leases | $1M | $2M | $2M | $0 | $125.0K | $493.0K | $849.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $42M | $37M | $40M | $33M | $28M | $28M | $31M | $25M | $25M | $24M | $30M | $26M | $22M | $29M | $26M | $31M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | |
| Retained Earnings | $-691M | $-638M | $-588M | $-537M | $-487M | $-417M | $-368M | $-321M | $-280M | $-238M | $-201M | $-177M | $-138M | $-106M | $-48M | $-21M | |
| AOCI | $-134.0K | $127.0K | $1M | $973.0K | $607.0K | $505.0K | $-133.0K | $970.0K | $-476.0K | $-331.0K | $-129.0K | $-1M | $-2M | $-1M | $-3M | $-4M | |
| Stockholders' Equity | $322M | $366M | $409M | $451M | $492M | $552M | $590M | $628M | $656M | $426M | $454M | $469M | $500M | $486M | $535M | $586M | |
| Liabilities + Equity | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Shares Outstanding | 64,345,770 | 61,451,380 | 60,244,136 | 59,076,259 | 59,074,391 | 58,698,919 | 58,510,610 | 58,141,130 | 57,871,638 | 43,065,645 | 42,900,083 | 42,760,644 | 42,735,304 | 39,343,601 | 45,796,449 | 45,743,027 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $79.0K | $79.0K | $79.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $80.0K | $81.0K | $72.0K | $59.0K | $9.0K | |
| Stock-based Comp | $8M | $8M | $7M | $9M | $10M | $9M | $10M | $9M | $11M | $8M | $8M | $8M | $8M | $7M | $8M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $-4M | · | · | · | $-9M | · | · | · | $-366.0K | · | · | |
| Operating Cash Flow | $-38M | $-46M | $-38M | $-37M | $-58M | $-43M | $-37M | $-34M | $-36M | $-38M | $-18M | $-34M | $-31M | $-51M | $-25M | $-54M | |
| CapEx | · | · | $11.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $49.0K | $159.0K | $882.0K | $251.0K | |
| Investing Cash Flow | $41M | $32M | $22M | $67M | $53M | $37M | $16M | $20M | $-185M | $13M | $51M | $-43M | $12M | $15M | $-29M | $-58M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | $38M | $-36.0K | $0 | $-4M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36.0K | · | · | |
| Financing Cash Flow | $1M | $380.0K | $715.0K | $0 | $373.0K | $0 | $2M | $1M | $262M | $1M | $248.0K | $112.0K | $39M | $2M | $-33M | $1M | |
| Taxes Paid | · | · | $0 | $0 | $-3M | $0 | $0 | $0 | $2M | $-4M | $-9M | $0 | $5M | $75.0K | $5M | $33M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-38M | · | · | · | $-51M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.2% | -10.1% | · | -8.9% | -11.7% | -9.4% | · | -7.1% | -7.0% | -7.7% | · | -7.0% | -5.4% | -12.2% | · | -4.6% | |
| ROE | -13.2% | -10.8% | · | -9.4% | -12.2% | -9.9% | · | -7.4% | -7.3% | -8.2% | · | -7.4% | -5.8% | -12.8% | · | -4.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -9.7% | -7.5% | -12.9% | · | -4.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 10.3 | · | 10.4 | 9.8 | 11.6 | · | 24.5 | 28.9 | 20.3 | · | 20.3 | 25.3 | 15.2 | · | 21.5 | |
| Quick Ratio | 8.2 | 10.0 | · | 10.2 | 9.5 | 11.1 | · | 23.9 | 28.2 | 19.7 | · | 19.9 | 25.0 | 14.9 | · | 21.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.00 | $5.96 | · | $7.64 | $8.33 | $9.40 | · | $10.80 | $11.34 | $9.88 | · | $10.96 | $11.69 | $12.34 | · | $12.81 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.89 | · | · | · | $-1.25 | · | · | |
| Cash / Share | $1.22 | $1.22 | · | $1.75 | $1.23 | $1.31 | · | $1.76 | $1.99 | $1.72 | · | $1.52 | $3.32 | $3.10 | · | $5.30 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | $-3.73 | $-3.36 | $1.23 | · | $2.20 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-205M | $-221M | · | $-217M | $-207M | $-179M | · | $-144M | $-142M | $-132M | · | $-156M | $-142M | $65M | · | $105M | |
| Market Cap | $1.17B | $873M | · | $350M | $445M | $444M | · | $973M | $1.01B | $734M | · | $387M | $460M | $402M | · | $586M | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | -2.4 | -3.2 | 8.3 | · | 5.8 | |
| P/B | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Tangible Book | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Cash Flow | · | -19.0 | · | · | · | -10.3 | · | · | · | -19.2 | · | · | · | -7.9 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | -41.2% | -31.2% | 12.0% | · | 17.2% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | · | · | · | $0 | $19M |
| Margen Operativo % | · | · | · | · | -358.7% |
| Beneficio neto | $-220M | $-167M | $-153M | $111M | $-66M |
| EPS Diluido | · | · | $-3.69 | $2.38 | $-1.52 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 |
| Ratio Rápido | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-176M | $-145M | $-134M | $-128M | · |
Propietarios institucionales (13F) 196 declarantes · $1.3B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
196
Valor en tenencia
$1.3B
Nuevas posiciones
32
Posiciones cerradas
19
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 32 (-8 vs trimestre anterior) | 19 (+4 vs trimestre anterior) | 82 (+22 vs trimestre anterior) | 47 (+3 vs trimestre anterior) | +6.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | $177 207 720 | 9 731 341 | 13,90% | Acciones |
| Lynx1 Capital Management LP | $163 225 335 | 8 963 500 | 12,81% | Acciones |
| BVF INC/IL | $104 719 937 | 5 750 683 | 8,22% | Acciones |
| BlackRock, Inc. | $95 288 670 | 5 232 766 | 7,48% | Acciones |
| STATE STREET CORP | $66 805 698 | 3 668 627 | 5,24% | Acciones |
| Kynam Capital Management, LP | $56 708 344 | 3 114 132 | 4,45% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $47 602 142 | 2 614 066 | 3,73% | Acciones |
| RTW INVESTMENTS, LP | $43 054 759 | 2 364 347 | 3,38% | Acciones |
| Siren, L.L.C. | $34 478 996 | 1 893 410 | 2,71% | Acciones |
| VANGUARD GROUP INC | $34 139 516 | 3 298 504 | 2,68% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $28 182 326 | 1 547 309 | 2,21% | Acciones |
| Blue Owl Capital Holdings LP | $28 039 102 | 1 539 764 | 2,20% | Acciones |
| Venrock Adviser, LLC | $25 129 163 | 1 379 965 | 1,97% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $19 714 346 | 1 082 611 | 1,55% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $19 061 499 | 1 046 694 | 1,50% | Acciones |
| GOLDMAN SACHS GROUP INC | $18 239 100 | 1 001 598 | 1,43% | Acciones |
| Affinity Asset Advisors, LLC | $15 947 590 | 875 760 | 1,25% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13 452 474 | 738 741 | 1,06% | Acciones |
| BOONE CAPITAL MANAGEMENT LLC | $12 827 889 | 704 442 | 1,01% | Acciones |
| Elmind Capital, LP | $12 564 900 | 690 000 | 0,99% | Acciones |
| MORGAN STANLEY | $11 454 726 | 629 035 | 0,90% | Acciones |
| TWIN FOCUS CAPITAL PARTNERS, LLC | $10 843 855 | 595 489 | 0,85% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $10 586 165 | 581 338 | 0,83% | Acciones |
| NORTHERN TRUST CORP | $10 399 367 | 571 080 | 0,82% | Acciones |
| BANK OF AMERICA CORP /DE/ | $9 293 018 | 510 325 | 0,73% | Acciones |
| Nuveen, LLC | $8 594 154 | 471 947 | 0,67% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8 450 059 | 464 034 | 0,66% | Acciones |
| PERCEPTIVE ADVISORS LLC | $7 766 164 | 426 478 | 0,61% | Acciones |
| TCG Crossover Management, LLC | $7 407 573 | 406 786 | 0,58% | Acciones |
| CITADEL ADVISORS LLC | $7 238 184 | 397 484 | 0,57% | Acciones |
| DEUTSCHE BANK AG\ | $6 971 516 | 382 840 | 0,55% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $6 612 707 | 363 136 | 0,52% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $6 304 885 | 346 232 | 0,49% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $5 951 228 | 326 811 | 0,47% | Acciones |
| GREAT POINT PARTNERS LLC | $5 463 000 | 300 000 | 0,43% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $5 326 425 | 292 500 | 0,42% | Acciones |
| JPMORGAN CHASE & CO | $5 206 063 | 282 631 | 0,41% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $4 963 700 | 272 581 | 0,39% | Acciones |
| Bleichroeder LP | $4 552 500 | 250 000 | 0,36% | Acciones |
| UBS Group AG | $4 527 498 | 248 627 | 0,36% | Acciones |
| FMR LLC | $4 372 486 | 240 115 | 0,34% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4 333 980 | 238 000 | 0,34% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $4 258 263 | 233 842 | 0,33% | Acciones |
| PFM Health Sciences, LP | $3 504 369 | 192 442 | 0,27% | Acciones |
| MOORE CAPITAL MANAGEMENT, LP | $3 458 917 | 189 946 | 0,27% | Acciones |
| Bank of New York Mellon Corp | $3 114 469 | 171 031 | 0,24% | Acciones |
| Squarepoint Ops LLC | $3 061 411 | 168 117 | 0,24% | Acciones |
| PRUDENTIAL FINANCIAL INC | $3 051 177 | 167 555 | 0,24% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $2 999 478 | 164 716 | 0,24% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $2 846 533 | 156 317 | 0,22% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 19 de enero de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 23 insiders · 12 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Nadim Ahmed | President and CEO | 24 de febrero de 2026 S | 390 803 | 0 | 3 | $-517 990 |
| Owen Hughes | President and CEO | 12 de enero de 2021 P | 506 226 | 0 | 0 | $0 |
| Mary Kay Fenton | Chief Financial Officer | 30 de junio de 2026 A | 127 921 | 0 | 1 | $-59 901 |
| Jeffrey Trigilio | Chief Financial Officer | 22 de febrero de 2024 A | 133 919 | 0 | 0 | $0 |
| Jennifer Michaelson | Chief Scientific Officer | 8 de septiembre de 2026 M | 158 844 | 0 | 18 | $-1 615 830 |
| Jacquelyn L Sumer | Chief Legal Officer | 30 de junio de 2026 A | 130 559 | 0 | 3 | $-136 724 |
| Jeffrey Alan Jones | Chief Medical Officer | 24 de febrero de 2026 S | 159 968 | 0 | 3 | $-178 948 |
| Corrine Savill | Chief Business Officer | 18 de febrero de 2026 A | 240 990 | 0 | 0 | $0 |
| Patrick Baeuerle | Chief Scientific Officer | 17 de febrero de 2023 A | 76 000 | 0 | 0 | $0 |
| Leigh Zawel | Chief Scientific Officer, Small Molecules | 11 de febrero de 2022 A | 69 785 | 0 | 0 | $0 |
| Raymond T Keane | Chief Legal Officer | 11 de febrero de 2022 A | 24 124 | 0 | 0 | $0 |
| Jon Marc Wigginton | Chief Medical Officer | 7 de enero de 2021 A | · | 0 | 0 | $0 |
| Mittie Doyle | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| David D. Meek | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| Anthony Rosenberg | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| Stephen W Webster | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| Andrew R Allen | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| Mary Thistle | Consejero | 16 de junio de 2026 A | · | 0 | 0 | $0 |
| David P. Ryan | Consejero | 12 de junio de 2025 A | · | 0 | 0 | $0 |
| Anne-Marie Martin | Consejero | 12 de junio de 2025 A | · | 0 | 0 | $0 |
| Thomas Ebeling | Consejero | 10 de junio de 2024 M | 186 653 | 0 | 0 | $0 |
| ANSBERT GADICKE | Consejero | 22 de junio de 2022 A | 7 648 268 | 0 | 0 | $0 |
| Morana Jovan-Embiricos | Propietario del 10% | 24 de junio de 2022 M | 207 803 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 32 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,81% | 22 687 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,30% | 205 569 SH | 11 de septiembre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,27% | 80 791 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 114 553 SH | 19 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 14 989 SH | 1 de octubre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,08% | 1 104 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 345 074 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 53 076 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 4 556 SH | 1 de octubre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 100 878 SH | 1 de octubre de 2026 | Diario |
| IWM · iShares Trust | 0,04% | 1 560 323 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,03% | 28 892 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 348 112 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,02% | 188 192 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 621 038 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 113 923 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17 979 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 2 558 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2 236 SH | 10 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,01% | 170 697 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 292 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3 792 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 16 447 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17 021 SH | 4 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 72 679 SH | 11 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 17 018 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 929 766 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 664 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 567 459 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 2 054 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 10 177 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 117 043 SH | 11 de septiembre de 2026 | Diario |
CGEM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 19 analistas
COMPRA
Objetivo mediano
$35.00
+125,7%
9 47,4%
Compra fuerte
9 47,4%
Compra
1 5,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
11 analistas · 2026-10-02Objetivo medio $33.45 +115,7%
← Por Debajo de Todos los Objetivos
Precio Actual $15.51
Mín$23.00
Media$33.45
Máx$42.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| AKTS | · | · | · | · | · | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| ODTX | · | · | · | · | · | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026